<DOC>
	<DOCNO>NCT01394887</DOCNO>
	<brief_summary>Hypothesis . To determine effect metformin concentration resistin insulin resistance inflammatory marker ( C-reactive protein , cytokine , body weight , HbA1c , among others ) minor glucose intolerance . Children glucose intolerance give either metformin placebo 12 consecutive week . High sensitivity C-reactive protein , TNF-alpha , IL-6 , IL1-beta , resistin , leptin , adiponectin , glucose , insulin , HbA1c , lipid profile transaminase measure begin end period . Statistical analysis : Student test ; Friedman Kruskal Wallis test use . Variables adjust : sex , age , baseline BMI percentage weight change .</brief_summary>
	<brief_title>Metformin &amp; Inflammation Pre-diabetic Children</brief_title>
	<detailed_description>Experimental , double-blind , randomize , prospective , placebo-controlled study . Patients age 4-17 year old select endocrine outpatient clinic Hospital de Pediatria del CMN `` Siglo XXI '' , patient parent sign inform consent . They schedule fast oral glucose tolerance test ( OGTT ) 1.75 mg/kg oral glucose . A blood sample take antecubital vein baseline 120 minute . A high carbohydrate diet indicate 3 day prior test . All patient diagnose glucose intolerance invite participate . All follow aerobic program 30 45 minute every day , isocaloric diet moment inclusion throughout study period , order decrease effect nutrition modification metabolic vascular parameter . A complete medical history take , record family background diabetes plus blood pressure , heart rate Tanner stage13 . Age , body weight , height , waist circumference measure record percentile accord age gender , body mass index calculate ( kg/m2 ) , record percentile accord reference value Center Disease Control , Atlanta , GA14 . Subjects randomize metformin placebo . Both metformin placebo place capsule gelatin blind aspect . Treatments administer 3 month . Children evaluate monthly , measure transaminase , glucose , creatinine , uric acid . Measurements C reactive protein , cytokine , adipokines , insulin concentration , HbA1c level lipid profile make begin end study . Insulin resistance assay HOMA-IR index . Beta cell function determine use HOMA-β . These complemented evaluation diet , physical activity , physical examination . Treatment assignment : Two group form , randomly assign use table random number previously design Epistat statistic package ( Round Rock , Texas ) . When screen finish , every child receive consecutive number . This number correspond envelope card identify his/her medication flask , contain 60 tablet 850 mg placebo . The content capsule identify , physician patient blind . A blinded member study prepare flask label . Participants take capsule twice daily , breakfast dinner . They instruct take medication meal order decrease possibility adverse effect ( nausea , meteorism , diarrhea ) , check every visit . Hepatic function monitor study . FPG , total cholesterol , HDL-cholesterol , triglyceride , liver function test creatinine measure use Synchron CX analyzer ( Beckman Systems , Fullerton CA ) , accord standard protocol . The coefficient variation cholesterol HDL-cholesterol 3.3 % 2.5 % respectively . Plasma leptin , adiponectin insulin concentration measure duplicate radioinmmunoassay ( Linco Research Inc , St Charles , MO ) . HbA1c determine whole blood use ion exchange high performance liquid chromatography ( normal range 4-6 ) . Plasma resistin measure use Human Resistin Elisa Kit ( PeproTech , Rock Hill , NJ , USA ) read Multiscan EX , Lab Systems , USA ) . Plasma IL-6 , IL1-b , TNF-α concentration determine ELISA use Quantike HS Human Immunoassay Kits ( R &amp; D Systems , Minneapolis , MN , USA ) , plasma C-reactive protein ( hs-CRP ) measure use highly sensitive human CRP ELISA Kit ( Alpha diagnostic international , San Antonio , TX , USA ) accord manufacturer 's instruction read ELISA reader ( Sunrise , Tecan USA , Durham NC , USA ) .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Glucose Intolerance</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>pediatric patient glucose intolerance per ADA criterion , free acute chronic inflammatory process 3 month prior recruitment , 417 year age previous personal history diabetes demonstrate diabetes OGTT curve , chronic renal disease serum creatinine 1.4 mg/dl ( female ) 1.5 ( male ) , active hepatic disease , smoking , primary dislipidemia , heart problem , steroid , chronic metabolic acidosis , receive antihypertensive hypolipemia hypoglucemia medication</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>July 2002</verification_date>
	<keyword>Metformin , inflammation</keyword>
	<keyword>resistin</keyword>
	<keyword>impaired glucose tolerance</keyword>
	<keyword>child</keyword>
</DOC>